Screening for CD relies on highly sensitive and specific serology tests such as tissue transglutaminase (tTG) IgA, endomysial (EMA) IgA, and deaminated gliadin peptide (DGP) IgA and IgG antibodies, especially if IgA deficient [90]. The gene discussed is TGM2; the disease is Cowden disease.